GL1X · GenesisL1 explorer

Research workbench

Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)

Analyse Fragment-based screening identifies a new area for inhibitor binding to… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4BDH
Type
protein
Length
282 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase CHK2
EC
2.7.11.1
UniProt
O96017
Ligands
WVI, NO3, CL
Pockets
3 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase CHK2 (EC 2.7.11.1)protein28241% helix, 16% strandO96017

Ligands and binding sites

  • WVI · 3-methyl-4-(thiophen-2-yl)-1H-pyrazol-5-amine · ligand · chains A
  • NO3 · Nitrate ion · ion · chains A
  • CL · Chloride ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11900.560.7928WVI, EDO
2760.330.7417empty
3590.270.7315empty

Compared structures

  • 4BDH · Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase… · the same entry in another collection · chain A against A, TM-score 1.00
  • O96017 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK2 (O96017) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.